Trastuzumab or lapatinib with standard chemotherapy for HER2-positive breast cancer: results from the GEICAM/2006-14 trial.

Saved in:

Bibliographic Details
Title:	Trastuzumab or lapatinib with standard chemotherapy for HER2-positive breast cancer: results from the GEICAM/2006-14 trial.
Authors:	Alba, E¹, Albanell, J², de la Haba, J³, Barnadas, A⁴, Calvo, L⁵, Sánchez-Rovira, P⁶, Ramos, M⁷, Rojo, F⁸, Burgués, O⁹, Carrasco, E¹⁰, Caballero, R¹⁰, Porras, I³, Tibau, A⁴, Cámara, M C¹⁰, Lluch, A⁹
Source:	British Journal of Cancer. 3/4/2014, Vol. 110 Issue 5, p1139-1147. 9p. 2 Diagrams, 5 Charts.
Database:	Academic Search Ultimate

Description
ISSN:	00070920
DOI:	10.1038/bjc.2013.831